Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma

Conditions

• Stomach Neoplasms

Interventions

• DRUG: Fruquintinib
• DRUG: Sintilimab

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology